Search Results: Awelumab
Sorry, the article you're looking for isn't specifically available. Here are related topics:
Avelumab
Jumat, 2023-10-27 06:12:24Avelumab, awelumab (nazwa handlowa Bavencio) – ludzkie przeciwciało monoklonalne wyprodukowane przez firmy farmaceutyczne Merck KGaA, Pfizer i Eli Lilly...
Click to read more »Winblastyna
Minggu, 2026-01-04 01:48:46necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »ATC (L01)
Jumat, 2026-02-20 04:33:47niwolumab L 01 FF 02 – pembrolizumab L 01 FF 03 – durwalumab L 01 FF 04 – awelumab L 01 FF 05 – atezolizumab L 01 FF 06 – cemiplimab L 01 FF 07 – dostarlimab...
Click to read more »Doksorubicyna
Senin, 2025-08-11 15:47:20necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Rak pęcherza moczowego
Jumat, 2026-05-08 15:12:42fazy wywoływał odpowiedź obiektywną u 17,8% chorych. Awelumab jest przeciwciałem anty-PD-L1. Awelumab w badaniu na 44 chorych w leczeniu chorych opornych...
Click to read more »Rytuksymab
Minggu, 2026-01-04 12:31:56necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Paklitaksel
Rabu, 2023-10-04 00:56:49necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Cyklofosfamid
Kamis, 2024-09-19 06:10:57necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Celekoksyb
Senin, 2026-04-20 01:31:58necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Olaparyb
Kamis, 2023-03-02 06:02:53necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Hydroksykarbamid
Sabtu, 2026-01-03 02:22:51necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Leki alkilujące
Jumat, 2024-01-19 15:41:52necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Bortezomib
Selasa, 2025-12-30 01:36:03necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Gemcytabina
Jumat, 2024-09-20 05:53:52necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Taksany
Rabu, 2023-01-11 01:13:46necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Tritlenek diarsenu
Selasa, 2026-03-03 19:36:18necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Karmustyna
Sabtu, 2026-01-03 00:12:02necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Leki cytostatyczne
Senin, 2023-01-09 19:20:45necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Lomustyna
Sabtu, 2026-01-03 10:25:22necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Winorelbina
Jumat, 2021-07-23 07:37:11necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Tretynoina
Minggu, 2026-02-15 01:37:54necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Cisplatyna
Sabtu, 2026-04-18 01:55:30necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Imatynib
Rabu, 2026-03-04 11:22:04necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »5-Fluorouracyl
Minggu, 2025-06-29 00:25:33necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Metotreksat
Rabu, 2025-10-01 16:56:35necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Docetaksel
Kamis, 2024-08-22 19:34:44necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Pembrolizumab
Senin, 2024-01-29 21:21:15necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Trastuzumab
Jumat, 2024-04-26 10:52:08necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Kapecytabina
Minggu, 2026-01-04 02:58:21necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Winkrystyna
Rabu, 2023-01-11 06:18:09necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Pazopanib
Minggu, 2026-01-04 04:51:00necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Sorafenib
Minggu, 2023-07-02 21:28:32necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Karboplatyna
Sabtu, 2026-04-18 07:21:23necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Oksaliplatyna
Minggu, 2026-01-04 01:12:34necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Regorafenib
Jumat, 2024-08-23 02:22:56necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Beksaroten
Minggu, 2026-01-04 17:48:26necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Bleomycyna
Minggu, 2025-11-23 07:41:32necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Kladrybina
Minggu, 2026-01-04 01:49:22necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Etopozyd
Senin, 2026-01-19 16:12:46necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Temozolomid
Minggu, 2024-09-08 03:01:35necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Niwolumab
Minggu, 2024-03-31 18:52:17necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Chlorometyna
Senin, 2025-01-13 01:46:19necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Trabektedyna
Rabu, 2024-05-22 16:34:16necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Melfalan
Minggu, 2026-01-04 01:50:34necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Ifosfamid
Sabtu, 2026-05-23 01:17:01necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Arabinozyd cytozyny
Jumat, 2024-09-20 05:55:18necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Tebentafusp
Senin, 2026-03-09 01:41:31necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Ewerolimus
Minggu, 2026-01-04 11:55:31necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Merkaptopuryna
Selasa, 2026-03-24 08:05:39necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Prokarbazyna
Sabtu, 2026-01-03 10:25:24necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Alemtuzumab
Senin, 2024-04-15 01:30:08necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Busulfan
Minggu, 2023-01-08 23:55:11necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Erlotynib
Minggu, 2026-01-04 03:00:45necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Dakarbazyna
Sabtu, 2022-10-15 20:30:54necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Ipilimumab
Senin, 2024-09-16 14:08:20necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Nilotynib
Sabtu, 2023-11-04 02:43:05necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Mitotan
Kamis, 2025-07-03 19:43:46necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Chlorambucyl
Minggu, 2026-01-04 01:51:49necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Daunorubicyna
Rabu, 2024-04-03 23:57:07necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Trastuzumab emtanzyna
Minggu, 2021-10-24 18:42:13necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Kabozantynib
Minggu, 2021-07-18 22:21:46necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Mitoksantron
Selasa, 2020-06-23 04:41:40necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Wemurafenib
Minggu, 2026-01-04 04:55:09necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Tiotepa
Rabu, 2023-08-30 06:14:59necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Worinostat
Rabu, 2024-06-19 08:12:20necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Alitretynoina
Minggu, 2026-01-04 18:11:13necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Sunitynib
Selasa, 2026-03-31 03:04:48necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Dasatynib
Minggu, 2026-01-04 15:22:49necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Ofatumumab
Jumat, 2026-01-23 09:33:17necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Irynotekan
Senin, 2026-01-05 01:57:54necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Daktynomycyna
Sabtu, 2026-04-18 05:44:14necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Cetuksymab
Rabu, 2025-04-16 02:47:44necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Epotilony
Kamis, 2023-05-18 06:02:29necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Afatynib
Minggu, 2026-01-04 09:49:51necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Gemtuzumab ozogamycyny
Rabu, 2024-11-27 03:07:50necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Temsirolimus
Kamis, 2024-01-11 17:10:33necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Gefitynib
Minggu, 2026-01-04 21:12:53necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Necitumumab
Sabtu, 2026-03-21 17:06:39necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Estramustyna
Minggu, 2024-09-15 04:14:50necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Asparaginaza
Minggu, 2026-01-04 07:47:24necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Mitomycyna
Jumat, 2022-07-22 14:46:33necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Bendamustyna
Sabtu, 2026-03-07 05:31:23necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Bewacyzumab
Jumat, 2023-11-10 22:15:07necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Pegaspargaza
Minggu, 2026-01-04 09:54:33necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Streptozotocyna
Minggu, 2023-11-26 23:25:54necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Romidepsyna
Kamis, 2025-09-18 05:49:45necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Idarubicyna
Selasa, 2020-06-23 04:37:06necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Kabazytaksel
Minggu, 2026-01-04 11:29:19necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Fludarabina
Jumat, 2026-05-01 01:15:50necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Lapatynib
Senin, 2024-12-23 21:19:51necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Nintedanib
Minggu, 2026-02-15 10:00:58necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Iksabepilon
Kamis, 2023-05-18 06:03:53necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Elotuzumab
Minggu, 2026-01-04 23:39:05necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Anagrelid
Kamis, 2026-03-05 01:22:27necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Katumaksomab
Minggu, 2026-01-04 21:22:38necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Pertuzumab
Rabu, 2022-03-23 03:08:45necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Epirubicyna
Minggu, 2026-01-04 01:49:01necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Erybulina
Jumat, 2020-11-13 20:49:05necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Nelarabina
Kamis, 2025-05-29 05:00:55necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Oblimersen
Minggu, 2018-01-21 13:35:17necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Panitumumab
Senin, 2024-02-19 23:10:47necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Palbocyklib
Sabtu, 2026-04-04 00:36:53necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Aksytynib
Jumat, 2025-03-28 01:16:48necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »Edrekolomab
Senin, 2023-05-08 18:46:23necitumumab L01FF – Inhibitory PD–1/PD–L1 niwolumab pembrolizumab durwalumab awelumab atezolizumab cemiplimab dostarlimab prolgolimab tyslelizumab retyfanlibab...
Click to read more »